Position in NVCR
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$287
+$80 QoQ
Shares Held
19
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#208
of 214 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Gen-Wealth Partners Inc holds $1,944,358 across 8 Medical Devices names. NVCR ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GEHC |
GE HealthCare Technologies Inc.
|
12,321 | $788,667 | |
| 2 | SYK |
Stryker Corp
|
1,235 | $388,827 | |
| 3 | ABT |
Abbott Laboratories
|
3,491 | $316,773 | |
| 4 | MDT |
Medtronic plc
|
3,905 | $305,488 | |
| 5 | BSX |
Boston Scientific Corp
|
2,481 | $105,889 | |
| 6 | ZBH |
Zimmer Biomet Holdings, Inc.
|
445 | $38,310 | |
| 7 | NVCR |
NovoCure Ltd
This page
|
19 | $287 | |
| 8 | PACB |
Pacific Biosciences Of California, Inc.
|
70 | $117 |
All Filings in NVCR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $287 | 19 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $207 | 19 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $245 | 19 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $245 | 19 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $338 | 19 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $338 | 19 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $566 | 19 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $296 | 19 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $325 | 19 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $296 | 19 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||